A novel approach to the study of solution structures and dynamic behavior of paclitaxel and docetaxel using fluorine-containing analogs as probes

Journal of the American Chemical Society

Volumn 119, Issue 24, 1997, Pages 5519-5527

  Ojima, Iwao ^a   Kuduk, Scott D ^a   Chakravarty, Subrata ^a   Ourevitch, Michèle ^b   Bégué, Jean Pierre ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b UNIVERSITÉ PARIS SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2',10 DIACETYL 3' DEPHENYL 3' (4 FLUOROPHENYL)DOCETAXEL; 3' DEPHENYL 3' (4 FLUOROPHENYL) 3'N DEBENZOYL 3'N (4 FLUOROBENZOYL)PACLITAXEL; 3' DEPHENYL 3' (4 FLUOROPHENYL)DOCETAXEL; DOCETAXEL; FLUORINE; PACLITAXEL; PACLITAXEL DERIVATIVE; SOLVENT; UNCLASSIFIED DRUG;

ARTICLE; CONFORMATION; DRUG STRUCTURE; MOLECULAR DYNAMICS; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE; NUCLEAR OVERHAUSER EFFECT; TEMPERATURE; X RAY ANALYSIS;

EID: 0030750497     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja9633777     Document Type: Article

References (50)

1. Georg, G. I.; Boge, T. C.; Cheruvallath, Z. S.; Clowers, J. S.; Harriman, G. C. B.; Hepperle, M.; Park, H. In Taxol®: Science and Applications; Suffness, M., Ed.; CRC Press: New York, 1995; pp 317-375.
2. Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I., Chen, T. T., Ojima, I., Vyas, D. M., Eds.; American Chemical Society: Washington DC, 1995.
3. Guénard, D.; Guéritte-Vogelein, F.; Potier, P. Acc. Chem. Res. 1993, 26, 160-167.
4. Suffness, M. Taxol: Science and Applications; CRC Press: New York, 1995.
5. Wani, M. C.; Taylor, H. L.; Wall, M. E.; Coggon, P.; McPhail, A. T. J. Am. Chem. Soc. 1971, 93, 2325-2327.
6. Shiff, P. B.; Fant, J.; Horwitz, S. B. Nature 1979, 277, 665-667.
7. Shiff, P. B.; Horwitz, S. B. Proc. Natl. Acad. Sci. U.S.A. 1980, 77, 1561.
8. Vallee, R. B. In Taxol®: Science and Applications; Suffness, M., Ed.; CRC Press: New York, 1995; pp 259-274.
9. Arbuck, S. G.; Blaylock, B. A. In Taxol®: Science and Applications; Suffness, M., Ed.; CRC Press: Boca Raton, 1995; pp 379-415.
10. Rowinsky, E. K.; Onetto, N.; Canetta, R. M.; Arbuck, S. G. Semin. Oncol. 1992, 19, 646-662.
11. Nogales, E.; Wolf, S. G.; Khan, I. A.; Ludeña, R. F.; Downing, K. H. Nature 1995, 375, 424-427.
12. Rao, S.; Horwitz, S. B.; Ringel, I. J. Natl. Cancer Inst. 1992, 84, 785-788.
13. (a) Rao, S.; Krauss, N. E.; Heerding, J. M.; Swindell, C. S.; Ringel, I.; Orr, G. A.; Horwitz, S. B. J. Biol. Chem. 1994, 269, 3132-3134.
14. (b) Rao, S.; Orr, G. A.; Chaudhary, A. G., Kingston, D. G. I.; Horwitz, S. B. J. Biol. Chem. 1995, 270, 20235-20238.
15. Dasgupta, D.; Park, H.; Harriman, G. C. B.; Georg, G. I.; Himes, R. H. J. Med. Chem. 1994, 37, 2976-2980.
16. Horwitz, S. B.; Rao, S.; Krauss, N. E.; Heerding, J. M.; Swindell, C. S.; Ringel, I.; Orr, G. A. In Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I., Chen, T. T., Ojima, I., Vyas, D. M., Eds.; ACS Symposium Series 583; American Chemical Society: Washington, DC, 1995; pp 154-161.
17. Ojima, I.; Duclos, D.; Dormán, G.; Simonot, B.; Prestwich, G. D.; Rao, S.; Lerro, K. A.; Horwitz, S. B. J. Med. Chem. 1995, 38, 3891-3894.
18. Ojima, I.; Slater, J. C.; Michaud, E.; Kuduk, S. D.; Bounaud, P.-Y.; Vrignaud, P.; Bissery, M.-C.; Veith, J.; Pera, P.; Bernacki, R. J. J. Med. Chem. 1996, 39, in press.
19. Ojima, I.; Park, Y. H.; Fenoglio, I.; Duclos, O.; Sun, C.-M.; Kuduk, S. D.; Zucco, M.; Appendino, G.; Pera, P.; Veith, J. M.; Bernacki, R. J.; Bissery, M.-C.; Combeau, C.; Vrignaud, P.; Riou, J. F.; Lavelle, F. In Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I., Chen, T. T., Ojima, I., Vyas, D. M., Eds.; ACS Symposium Series 583; American Chemical Society: Washington, DC, 1995; pp 262-275.
20. Ojima, I.; Park, Y. H.; Sun, C.-M.; Fenoglio, I.; Appendino, G.; Pera, P.; Bernacki, R. J. J. Med. Chem. 1994, 37, 1408-1410.
21. Ojima, I.; Fenoglio, I.; Park, Y. H.; Pera, P.; Bernacki, R. J. Bioorg. Med. Chem. Lett. 1994, 4, 1571-1576.
22. Ojima, I.; Fenoglio, I.; Park, Y. H.; Sun, C.-M.; Appendino, G.; Pera, P.; Bernacki, R. J. J. Org. Chem. 1994, 59, 515-517.
23. Ojima, I.; Duclos, O.; Zucco, M.; Bissery, M.-C.; Combeau, C.; Vrignaud, P.; Riou, J. F.; Lavelle, F. J. Med. Chem. 1994, 37, 2602-2608.
24. Ojima, I.; Duclos, O.; Kuduk, S. D.; Sun, C.-M.; Slater, J. C.; Lavelle, F.; Veith, J. M.; Bernacki, R. J. Bioorg. Med. Chem. Lett. 1994, 4, 2631-2634.
25. Ojima, I.; Kuduk, S. D.; Slater, J. C.; Gimi, R. H.; Sun, C. M. Tetrahedron 1996, 52, 209-224.
26. Vander Velde, D. G.; Georg, G. I.; Grunewald, G. L.; Gunn, C. W.; Mitscher, L. A. J. Am. Chem. Soc. 1993, 115, 11650-11651.
27. Williams, H. J.; Scott, A. I.; Dieden, R. A.; Swindell, C. S.; Chirlian, L. E.; Franci, M. M.; Heerding, J. M.; Krauss, N. E. Can. J. Chem. 1994, 252-260.
28. Williams, H. J.; Scott, A. I.; Dieden, R. A.; Swindell, C. S.; Chirlian, L. E.; Francl, M. M.; Heerding, J. M.; Krauss, N. E. Tetrahedron 1993, 49, 6545-6560.
29. Dubois, J.; Guénard, D.; Guéritte-Voegelein, F.; Guedira, N.; Potier, P.; Gillet, B.; Beloeil, J.-C. Tetrahedron 1993, 49, 6533-6544.
30. Boge, T. C.; Himes, R. H.; Vander Velde, D. G.; Georg, G. I. J. Med. Chem. 1994, 37, 3337-3343.
31. Chmurny, G. N.; Hilton, B. D.; Brobst, S.; Look, S. A.; Witherup, K. M.; Beutler, J. A. J. Nat. Prod. 1992, 54, 416-423.
32. Hilton, B. D.; Chmurny, G. N.; Muschik, G. M. J. Nat. Prod. 1992, 55, 1157-1161.
33. Baker, J. K. Spectrosc. Lett. 1992, 25, 31-48.
34. Falzone, C. J.; Benesi, A. J.; Lecomte, J. T. Tetrahedron Lett. 1992, 33, 1169-1172.
35. Guéritte-Voegelein, F.; Mangatal, L.; Guénard, D.; Potier, P.; Guilhem, J.; Cesario, M.; Pascard, C. Acta Crstallogr. 1990, C46, 781-784.
36. Mastropaolo, D.; Camerman, A.; Luo, Y.; Brayer, G. D.; Camerman, N. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 6920-6924.
37. Georg, G. I. For a comprehensive review on the conformational studies on paclitaxel and docetaxel, see ref Georg 1995 #267.
38. Cachau, R. E.; Gussio, R.; Beutler, J. A.; Chmurny, G. N.; Hilton, B. D.; Muschik, G. M.; Erickson, J. W. Int. J. Supercomput. Appl. 1994, 8, 24-34.
39. Wiley, R. A.; Rich, D. H. Med. Res. Rev. 1993, 3, 327-384.
40. Georg, G. I.; Harriman, G. C. B.; Vander Velde, D. G.; Boge, T. C.; Cheruvallath, Z. S.; Datta, A.; Hepperle, M.; Park, H.; Himes, R. H.; Jayasinghe, L. In Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I., Chen, T. T., Ojima, I., Vyas, D. M., Eds.; American Chemical Society: Washington DC. 1995; pp 217-232.
41. Gao, Q.: Chen, S.-H. Tetrahedron Lett. 1996, 37, 3425-3428.
42. 50). A549: 3 , 35 nM; 4, 0.49 nM; paclitaxel, 3.6 nM. A121: 3, 76 nM; 4, 1.3 nM; paclitaxel, 6.3 nM.
43. 2O (3:1) could be performed at -20 °C (see ref 24), but we did not have any luck in keeping the solution from freezing below 0 °C although we were able to obtain clean NMR spectra in the glassy state at -20 °C.
44. 2O clearly shows a +127° dihedral angle that is, in fact, consistent with our RMD results in water just mentioned above. Consequently, we did not include these two conformers for detailed discussion in this paper.
45. Paloma, L. G.; Guy, R. K.; Wrasidlo, W.; Nicolaou, K. C. Chem. Biol. 1994, 2, 107-112.
46. Anderson, A. G.; Hermans, J. Proteins 1988, 3, 262-265.
47. Gilson, M. K.; Honig, B. Proteins 1988, 4, 7-18.
48. Biosym Technologies, I. Discover User Guide, Versions 95.0; 1994.
49. The energies for each conformer in an aqueous environment (9 Å layer of discrete water molecules) were calculated on the basis of average minimized energy of 25 frames collected at 1 ps intervals during the restrained molecular dynamics sequence (Discover 95.0, CVFF force field, Biosym Technologies/Molecular Simulations Inc.). The average total energies, incorporating a solvation term, calculated for each conformer were the following: conformer A (184.8 ± 3.6 kcal/mol), conformer B (179.8 ± 3.6 kcal/mol), and conformer C (183.9 ± 2.4 kcal/mol). The average solvation energies (calculated as the summation of intermolecular van der Waals and Coulombic interactions) for each conformer were the following: conformer A (-82.6 ± 6.1 kcal/mol), conformer B (-82.6 ± 4.4 kcal/ mol), and conformer C (-93.1 ± 4.1 kcal/mol). It should be noted that the numerical values of the total energies depend on the force field used and, as such, are meaningful only for the comparison of relative energies of conformers. It is assumed that the above calculation provides an average energy for the different conformers possible at ambient temperature for each constrained dihedral. However, different factors such as the orientation of water molecules in any particular frame may influence the energy terms without actually being associated with the actual conformational and solvation energies. This study must therefore be considered an approximation only. See the Experimental Section for further details.
50. Williams, H. J.; Moyna, G.; Scott, A. I.; Swindell, C. S.; Chirlian, L. E.; Heerding, J. M.; Williams, D. K. J. Med. Chem. 1996, 39, 1555-1559.